Insider · CIK 0001756929
Jesse Goodman
Files at NTLA (Intellia Therapeutics, Inc.), HLSQ (BiomX Inc.). First filing Jul 2, 2025, latest Jul 2, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NTLA: Intellia Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | Intellia Therapeutics, Inc. | $29k 3,094 shares | -11% | +49% from low-59% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | NTLA Intellia Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,547 | $9.56 | $15k | 25,906 | Jul 2, 2025 |
| Jul 1, 2025 | NTLA Intellia Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,547 | $9.23 | $14k | 24,359 | Jul 2, 2025 |
| Jun 11, 2025 | NTLA Intellia Therapeutics, Inc. | AGrant or award Common Stock | +8,000 | $0.00 | $0 | 27,453 | Jun 13, 2025 |
| Jun 11, 2025 | NTLA Intellia Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +11,450 | $0.00 | $0 | 11,450 | Jun 13, 2025 |
| Apr 14, 2025 | HLSQ BiomX Inc. | AGrant or award Common Stock Options - right to Buyderivative | +17,600 | $0.00 | $0 | 17,600 | Apr 21, 2025 |
| Apr 14, 2025 | HLSQ BiomX Inc. | AGrant or award Common Stock Options - right to Buyderivative | -17,600 | $0.00 | $0 | 17,600 | Apr 18, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.